Cargando…
Unraveling the Role of Hepatic PGC1α in Breast Cancer Invasion: A New Target for Therapeutic Intervention?
Breast cancer (BC) is the most common cancer among women worldwide and the main cause of cancer deaths in women. Metabolic components are key risk factors for the development of non-alcoholic fatty liver disease (NAFLD), which may promote BC. Studies have reported that increasing PGC1α levels increa...
Autores principales: | Ganesan, Kumar, Xu, Cong, Liu, Qingqing, Sui, Yue, Chen, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529029/ https://www.ncbi.nlm.nih.gov/pubmed/37759533 http://dx.doi.org/10.3390/cells12182311 |
Ejemplares similares
-
The Role of PGC1α in Alzheimer’s Disease and Therapeutic Interventions
por: Mota, Bibiana C., et al.
Publicado: (2021) -
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014) -
Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
por: Piccinin, Elena, et al.
Publicado: (2019) -
PGC‐1α, a potential therapeutic target against kidney aging
por: Lee, Gayoung, et al.
Publicado: (2019) -
PGC-1α-Targeted Therapeutic Approaches to Enhance Muscle Recovery in Aging
por: Petrocelli, Jonathan J., et al.
Publicado: (2020)